Hyperglycemia: GDNF-EGR1 pathway target renal epithelial cell migration and apoptosis in diabetic renal embryopathy

PLoS One. 2013;8(2):e56731. doi: 10.1371/journal.pone.0056731. Epub 2013 Feb 28.

Abstract

Maternal hyperglycemia can inhibit morphogenesis of ureteric bud branching, Glial cell line-derived neurotrophilic factor (GDNF) is a key regulator of the initiation of ureteric branching. Early growth response gene-1 (EGR-1) is an immediate early gene. Preliminary study found EGR-1 persistently expressed with GDNF in hyperglycemic environment. To evaluate the potential relationship of hyperglycemia-GDNF-EGR-1 pathway, in vitro human renal proximal tubular epithelial (HRPTE) cells as target and in vivo streptozotocin-induced mice model were used. Our in vivo microarray, real time-PCR and confocal morphological observation confirmed apoptosis in hyperglycemia-induced fetal nephropathy via activation of the GDNF/MAPK/EGR-1 pathway at E12-E15. Detachment between ureteric branch and metanephrons, coupled with decreasing number and collapse of nephrons on Day 1 newborn mice indicate hyperglycemic environment suppress ureteric bud to invade metanephric rudiment. In vitro evidence proved that high glucose suppressed HRPTE cell migration and enhanced GDNF-EGR-1 pathway, inducing HRPTE cell apoptosis. Knockdown of EGR-1 by siRNA negated hyperglycemic suppressed GDNF-induced HRPTE cells. EGR-1 siRNA also reduced GDNF/EGR-1-induced cRaf/MEK/ERK phosphorylation by 80%. Our findings reveal a novel mechanism of GDNF/MAPK/EGR-1 activation playing a critical role in HRPTE cell migration, apoptosis and fetal hyperglycemic nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Movement / drug effects
  • Early Growth Response Protein 1 / genetics
  • Early Growth Response Protein 1 / metabolism
  • Embryonic Development / genetics
  • Epithelial Cells / metabolism
  • Female
  • Gene Expression Profiling
  • Genome-Wide Association Study
  • Glial Cell Line-Derived Neurotrophic Factor / metabolism
  • Glial Cell Line-Derived Neurotrophic Factor / pharmacology
  • Humans
  • Hyperglycemia / complications*
  • Hyperglycemia / genetics
  • Kidney Diseases / etiology*
  • Kidney Diseases / genetics
  • Kidney Tubules, Proximal / embryology
  • Kidney Tubules, Proximal / metabolism
  • Kidney Tubules, Proximal / pathology
  • MAP Kinase Signaling System
  • Maternal Exposure / adverse effects*
  • Mice
  • Mitogen-Activated Protein Kinases / metabolism
  • Morphogenesis / genetics
  • Phosphorylation / drug effects
  • Pregnancy
  • Proto-Oncogene Proteins c-raf / metabolism
  • RNA Interference
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Signal Transduction

Substances

  • Early Growth Response Protein 1
  • Glial Cell Line-Derived Neurotrophic Factor
  • RNA, Messenger
  • Proto-Oncogene Proteins c-raf
  • Mitogen-Activated Protein Kinases

Grants and funding

This work was supported by the grant of National Science council, Taiwan. (NSC94-2314-B309-005 and NSC 96-2314-B-039-050-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.